Research Guide

What Is Retatrutide?

A plain-English guide to the triple GLP-1 / GIP / glucagon receptor agonist — what it is, how researchers describe its mechanism, its investigational status, and how to make sure the material you obtain is genuine.

A triple-agonist peptide

Retatrutide is an investigational peptide with a molecular weight of roughly 4,731 Da. What makes it notable in metabolic research is that it acts on three receptors at once: the GLP-1, GIP, and glucagon receptors. Compounds that engage a single receptor are called agonists; one that engages all three is a triple agonist. It remains an experimental compound — not an approved or licensed medicine — and is supplied here strictly for laboratory and research use.

The three receptors it targets

Researchers are interested in triple agonism because these three pathways influence glucose handling and energy metabolism in complementary ways:

GLP-1Glucagon-like peptide-1 receptor

An incretin receptor. In research it is associated with glucose-dependent insulin release, signalling related to appetite and satiety, and the rate of gastric emptying.

GIPGlucose-dependent insulinotropic polypeptide receptor

The other major incretin receptor, studied for its roles in insulin secretion and in how the body handles lipids and stores energy.

GlucagonGlucagon receptor

Associated in research with energy expenditure and with how the liver manages glucose and fat — the third arm that distinguishes a triple agonist from GLP-1-only compounds.

The combined effect of engaging all three is the active subject of ongoing study, and findings are still developing — see our summary of the clinical trial evidence for what has been reported so far. Nothing here describes an outcome in humans or constitutes medical advice.

Why purity and testing matter

The research-chemical market is unregulated, and quality varies enormously. Independent testing across the sector has repeatedly turned up material that is underdosed, mislabelled, or substituted with a cheaper or different compound than the label claims — and fabricated or unverifiable Certificates of Analysis are a well-known problem. You cannot judge purity by appearance, so the certificate is the only thing standing between you and an unknown.

The catch is that a PDF is easy to fake. A meaningful COA has to be independently verifiable — issued by a named laboratory and checkable against that lab’s own record, not just a document the seller hands over.

How to verify a Certificate of Analysis

  1. Check it names an independent laboratory and the method used (for peptides, HPLC).
  2. Look for a unique certificate ID and an integrity hash (e.g. SHA-256).
  3. Go to the laboratory’s own verification page and confirm the ID matches their record — the certificate should exist on the lab’s side, not only as a file from the seller.
  4. Be sceptical of “100% purity” or figures with no method, no lab, and no way to check them.

Our current batch

RETApro’s current Retatrutide is tested by PeptideVerify at 98.0% HPLC purity, with certificate ID PV-8B67BB-HAJY and a SHA-256 hash you can check against the lab’s record.

Handling & storage

Peptides are temperature-sensitive. Store at 2–8°C, keep away from direct light, and do not freeze. Once opened, keep refrigerated and use within the period given in the handling guidance supplied with your order. Cold-chain handling in transit matters as much as storage at rest, which is why every RETApro order ships in temperature-controlled packaging with gel ice packs.

Frequently asked questions

What is Retatrutide?

Retatrutide is an investigational peptide that acts on three receptors at once — GLP-1, GIP, and glucagon. Because it engages all three, it is described as a “triple agonist”. It has a molecular weight of about 4,731 Da and is studied in metabolic research. It is not an approved or licensed medicine anywhere, and RETApro supplies it strictly for laboratory and research use.

Is Retatrutide approved or legal?

Retatrutide is not approved or licensed as a medicine in the UK or elsewhere; it remains an investigational compound. In the UK it can be supplied for laboratory and research use only. By purchasing, you confirm you are acquiring it solely for research purposes and are responsible for the laws that apply to you.

How is Retatrutide different from single GLP-1 compounds?

Single-target compounds engage only the GLP-1 receptor. Retatrutide is studied because it engages GLP-1, GIP, and glucagon receptors together — a combination researchers are interested in for its effects on glucose and energy metabolism. The science is still emerging, which is exactly why research-grade material and accurate purity data matter.

How do I know the Retatrutide I buy is genuine?

Insist on a Certificate of Analysis that you can independently verify. Ours is issued by PeptideVerify, reports 98.0% HPLC purity, and carries a unique certificate ID (PV-8B67BB-HAJY) plus a SHA-256 integrity hash you can check against the lab’s own record — so you are not relying on a PDF a seller could edit.

How should Retatrutide be stored?

Store at 2–8°C, away from direct light, and do not freeze. Once opened, keep it refrigerated and use within the period noted in the accompanying handling guidance. Cold-chain handling in transit matters too, which is why every order ships in temperature-controlled packaging.

Research-grade Retatrutide, tested and verifiable

High-purity Retatrutide with an independently verifiable Certificate of Analysis, cold-chain shipped across the UK.

This guide is general information about a research compound and is not medical advice. Retatrutide is supplied strictly for laboratory and research use only — not for human or veterinary use, and not intended to diagnose, treat, cure, or prevent any disease.